<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230810000958&amp;utm_source=Chrome&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;v=2.17.9.post6+86293ac
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230810000958&amp;utm_source=Chrome&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;v=2.17.9.post6+86293ac" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Thu, 10 Aug 2023 04:10:00 +0000</lastbuilddate>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Testosterone and cardiovascular health</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37556598/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 9:ehad513. doi: 10.1093/eurheartj/ehad513. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37556598/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37556598</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad513>10.1093/eurheartj/ehad513</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37556598</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Andrew Elagizi</dc:creator>
<dc:creator>Felice L Gersh</dc:creator>
<dc:creator>Carl J Lavie</dc:creator>
<dc:creator>Jari A Laukkanen</dc:creator>
<dc:creator>James H O'Keefe</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Testosterone and cardiovascular health</dc:title>
<dc:identifier>pmid:37556598</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad513</dc:identifier>
</item>
<item>
<title>Out-of-Hospital Cardiac Arrest-One Size Does Not Fit All</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37556149/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Aug 9. doi: 10.1001/jamacardio.2023.2277. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37556149/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37556149</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.2277>10.1001/jamacardio.2023.2277</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37556149</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Nilesh Pareek</dc:creator>
<dc:creator>Thomas R Keeble</dc:creator>
<dc:creator>Shrilla Banerjee</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Out-of-Hospital Cardiac Arrest-One Size Does Not Fit All</dc:title>
<dc:identifier>pmid:37556149</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.2277</dc:identifier>
</item>
<item>
<title>Use the Receiver Operating Characteristic to Assess Model Accuracy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37556148/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Aug 9. doi: 10.1001/jamacardio.2023.2250. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37556148/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37556148</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.2250>10.1001/jamacardio.2023.2250</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37556148</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Harry B Burke</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Use the Receiver Operating Characteristic to Assess Model Accuracy</dc:title>
<dc:identifier>pmid:37556148</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.2250</dc:identifier>
</item>
<item>
<title>Use the Receiver Operating Characteristic to Assess Model Accuracy-Reply</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37556135/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Aug 9. doi: 10.1001/jamacardio.2023.2247. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37556135/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37556135</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.2247>10.1001/jamacardio.2023.2247</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37556135</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Xuan Wang</dc:creator>
<dc:creator>Brian Lee Claggett</dc:creator>
<dc:creator>Lu Tian</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Use the Receiver Operating Characteristic to Assess Model Accuracy-Reply</dc:title>
<dc:identifier>pmid:37556135</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.2247</dc:identifier>
</item>
<item>
<title>Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37556134/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS AND RELEVANCE: The findings of this study suggest that women who gave birth after ART were not at increased risk of CVD over a median follow-up of 11 years compared with those who conceived without ART. Longer-term studies are needed to further examine whether ART is associated with higher risk of CVD.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Aug 9. doi: 10.1001/jamacardio.2023.2324. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: The use of assisted reproductive technologies (ARTs) is steadily increasing worldwide. The outcomes associated with treatment for an individual's long-term health, including risk of cardiovascular disease (CVD), remain largely unknown, due to the small number of studies and their limited follow-up time.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To study whether the risk of CVD is increased among individuals who have given birth after ART compared with those who have given birth without ART.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: A registry-based cohort study was conducted using nationwide data from Denmark (1994-2014), Finland (1990-2014), Norway (1984-2015), and Sweden (1985-2015). Data analysis was conducted from January to August 2022. A total of 2 496 441 individuals with a registered delivery in the national birth registries during the study period were included, and 97 474 (4%) of these gave birth after ART.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURES: Data on ART conception were available from ART quality registries and/or medical birth registries.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Information on CVD was available from patient and cause of death registries. The risk of CVD was estimated with Cox proportional hazards regression, adjusting for age, calendar year of start of follow-up, parity, diagnosis of polycystic ovary syndrome, diabetes, chronic hypertension, and country.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Median follow-up was 11 (IQR, 5-18) years. The mean (SD) age of women with no use of ART was 29.1 (4.9) years, and the age of those who used ART was 33.8 (4.7) years. The rate of any CVD was 153 per 100 000 person-years. Individuals who gave birth after using ART had no increased risk of CVD (adjusted hazard ratio [AHR], 0.97; 95% CI, 0.91-1.02), with evidence of heterogeneity between the countries (I2 = 76%; P = .01 for heterogeneity). No significant differences in the risk of ischemic heart disease, cerebrovascular disease, stroke, cardiomyopathy, heart failure, pulmonary embolism, or deep vein thrombosis were noted with use of ART. However, there was a tendency for a modest reduction in the risk of myocardial infarction (AHR, 0.80; 95% CI, 0.65-0.99), with no notable heterogeneity between countries.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: The findings of this study suggest that women who gave birth after ART were not at increased risk of CVD over a median follow-up of 11 years compared with those who conceived without ART. Longer-term studies are needed to further examine whether ART is associated with higher risk of CVD.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37556134/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37556134</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.2324>10.1001/jamacardio.2023.2324</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37556134</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Maria C Magnus</dc:creator>
<dc:creator>Abigail Fraser</dc:creator>
<dc:creator>Siri E Håberg</dc:creator>
<dc:creator>Kristiina Rönö</dc:creator>
<dc:creator>Liv Bente Romundstad</dc:creator>
<dc:creator>Christina Bergh</dc:creator>
<dc:creator>Anne Lærke Spangmose</dc:creator>
<dc:creator>Anja Pinborg</dc:creator>
<dc:creator>Mika Gissler</dc:creator>
<dc:creator>Ulla-Britt Wennerholm</dc:creator>
<dc:creator>Bjørn Olav Åsvold</dc:creator>
<dc:creator>Deborah A Lawlor</dc:creator>
<dc:creator>Signe Opdahl</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies</dc:title>
<dc:identifier>pmid:37556134</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.2324</dc:identifier>
</item>
<item>
<title>Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults-When Null Results Matter</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37556127/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Aug 9. doi: 10.1001/jamacardio.2023.2333. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37556127/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37556127</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.2333>10.1001/jamacardio.2023.2333</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37556127</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Stephanie A Fisher</dc:creator>
<dc:creator>Sadiya S Khan</dc:creator>
<dc:creator>Priya M Freaney</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults-When Null Results Matter</dc:title>
<dc:identifier>pmid:37556127</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.2333</dc:identifier>
</item>
<item>
<title>Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: One-Year Outcomes of a Randomized Clinical Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37556123/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS AND RELEVANCE: This study found that a strategy of immediate coronary angiography does not provide clinical benefit compared with a delayed or selective invasive approach for patients 1 year after resuscitated OHCA of presumed coronary cause and without ST-segment elevation.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Aug 9. doi: 10.1001/jamacardio.2023.2264. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Myocardial infarction is a frequent cause of out-of-hospital cardiac arrest (OHCA). The long-term effect of early coronary angiography on patients with OHCA with possible coronary trigger but no ST-segment elevation remains unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To compare the clinical outcomes of early unselective angiography with the clinical outcomes of a delayed or selective approach for successfully resuscitated patients with OHCA of presumed cardiac origin without ST-segment elevation at 1-year follow-up.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: The TOMAHAWK trial was a multicenter, international (Germany and Denmark), investigator-initiated, open-label, randomized clinical trial enrolling 554 patients between November 23, 2016, to September 20, 2019. Patients with stable return of spontaneous circulation after OHCA of presumed cardiac origin but without ST-segment elevation on the postresuscitation electrocardiogram were eligible for inclusion. A total of 554 patients were randomized to either immediate coronary angiography after hospital admission or an initial intensive care assessment with delayed or selective angiography after a minimum of 24 hours. All 554 patients were included in survival analyses during the follow-up period of 1 year. Secondary clinical outcomes were assessed only for participants alive at 1 year to account for the competing risk of death.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERVENTIONS: Early vs delayed or selective coronary angiography and revascularization if indicated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Evaluations in this secondary analysis included all-cause mortality after 1 year, as well as severe neurologic deficit, myocardial infarction, and rehospitalization for congestive heart failure in survivors at 1 year.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 281 patients were randomized to the immediate angiography group and 273 to the delayed or selective group, with a median age of 70 years (IQR, 60-78 years). A total of 369 of 530 patients (69.6%) were male, and 268 of 483 patients (55.5%) had a shockable arrest rhythm. At 1 year, all-cause mortality was 60.8% (161 of 265) in the immediate angiography group and 54.3% (144 of 265) in the delayed or selective angiography group without significant difference between the treatment strategies, trending toward an increase in mortality with immediate angiography (hazard ratio, 1.25; 95% CI, 0.99-1.57; P = .05). For patients surviving until 1 year, the rates of severe neurologic deficit, myocardial infarction, and rehospitalization for congestive heart failure were similar between the groups.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: This study found that a strategy of immediate coronary angiography does not provide clinical benefit compared with a delayed or selective invasive approach for patients 1 year after resuscitated OHCA of presumed coronary cause and without ST-segment elevation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02750462.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37556123/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37556123</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.2264>10.1001/jamacardio.2023.2264</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37556123</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Steffen Desch</dc:creator>
<dc:creator>Anne Freund</dc:creator>
<dc:creator>Ibrahim Akin</dc:creator>
<dc:creator>Michael Behnes</dc:creator>
<dc:creator>Michael R Preusch</dc:creator>
<dc:creator>Thomas A Zelniker</dc:creator>
<dc:creator>Carsten Skurk</dc:creator>
<dc:creator>Ulf Landmesser</dc:creator>
<dc:creator>Tobias Graf</dc:creator>
<dc:creator>Ingo Eitel</dc:creator>
<dc:creator>Georg Fuernau</dc:creator>
<dc:creator>Hendrik Haake</dc:creator>
<dc:creator>Peter Nordbeck</dc:creator>
<dc:creator>Fabian Hammer</dc:creator>
<dc:creator>Stephan B Felix</dc:creator>
<dc:creator>Christian Hassager</dc:creator>
<dc:creator>Jesper Kjærgaard</dc:creator>
<dc:creator>Stephan Fichtlscherer</dc:creator>
<dc:creator>Jakob Ledwoch</dc:creator>
<dc:creator>Karsten Lenk</dc:creator>
<dc:creator>Michael Joner</dc:creator>
<dc:creator>Stephan Steiner</dc:creator>
<dc:creator>Christoph Liebetrau</dc:creator>
<dc:creator>Ingo Voigt</dc:creator>
<dc:creator>Uwe Zeymer</dc:creator>
<dc:creator>Michael Brand</dc:creator>
<dc:creator>Roland Schmitz</dc:creator>
<dc:creator>Jan Horstkotte</dc:creator>
<dc:creator>Claudius Jacobshagen</dc:creator>
<dc:creator>Janine Pöss</dc:creator>
<dc:creator>Mohamed Abdel-Wahab</dc:creator>
<dc:creator>Philipp Lurz</dc:creator>
<dc:creator>Alexander Jobs</dc:creator>
<dc:creator>Suzanne de Waha</dc:creator>
<dc:creator>Denise Olbrich</dc:creator>
<dc:creator>Frank Sandig</dc:creator>
<dc:creator>Inke R König</dc:creator>
<dc:creator>Sabine Brett</dc:creator>
<dc:creator>Maren Vens</dc:creator>
<dc:creator>Kathrin Klinge</dc:creator>
<dc:creator>Holger Thiele</dc:creator>
<dc:creator>TOMAHAWK Investigators</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: One-Year Outcomes of a Randomized Clinical Trial</dc:title>
<dc:identifier>pmid:37556123</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.2264</dc:identifier>
</item>
<item>
<title>JAMA Cardiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37555851/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Aug 1;8(8):714. doi: 10.1001/jamacardio.2022.3448.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37555851/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37555851</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2022.3448>10.1001/jamacardio.2022.3448</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37555851</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:date>2023-08-09</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>JAMA Cardiology</dc:title>
<dc:identifier>pmid:37555851</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2022.3448</dc:identifier>
</item>
<item>
<title>Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37555393/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSION: Aortic valve replacement is associated with rapid recovery of the bleeding diathesis in Heyde syndrome and gastrointestinal bleeding cessation. Residual valve disease compromises clinical benefits.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093/eurheartj/ehad340. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Heyde syndrome is the co-occurrence of aortic stenosis, acquired von Willebrand syndrome, and gastrointestinal bleeding. Aortic valve replacement has been demonstrated to resolve all three associated disorders. A systematic review and meta-analysis were performed to obtain best estimates of the effect of aortic valve replacement on acquired von Willebrand syndrome and gastrointestinal bleeding.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: A literature search was performed to identify articles on Heyde syndrome and aortic valve replacement up to 25 October 2022. Primary outcomes were the proportion of patients with recovery of acquired von Willebrand syndrome within 24 h (T1), 24-72 h (T2), 3-21 days (T3), and 4 weeks to 2 years (T4) after aortic valve replacement and the proportion of patients with cessation of gastrointestinal bleeding. Pooled proportions and risk ratios were calculated using random-effects models. Thirty-three studies (32 observational studies and one randomized controlled trial) on acquired von Willebrand syndrome (n = 1054), and 11 observational studies on gastrointestinal bleeding (n = 300) were identified. One study reported on both associated disorders (n = 6). The pooled proportion of Heyde patients with acquired von Willebrand syndrome recovery was 86% (95% CI, 79%-91%) at T1, 90% (74%-96%) at T2, 92% (84%-96%) at T3, and 87% (67%-96%) at T4. The pooled proportion of Heyde patients with gastrointestinal bleeding cessation was 73% (62%-81%). Residual aortic valve disease was associated with lower recovery rates of acquired von Willebrand syndrome (RR 0.20; 0.05-0.72; P = 0.014) and gastrointestinal bleeding (RR 0.57; 0.40-0.81; P = 0.002).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Aortic valve replacement is associated with rapid recovery of the bleeding diathesis in Heyde syndrome and gastrointestinal bleeding cessation. Residual valve disease compromises clinical benefits.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37555393/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37555393</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad340>10.1093/eurheartj/ehad340</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37555393</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Lia C M J Goltstein</dc:creator>
<dc:creator>Maxim J P Rooijakkers</dc:creator>
<dc:creator>Marlijn Hoeks</dc:creator>
<dc:creator>Wilson W L Li</dc:creator>
<dc:creator>Marleen H van Wely</dc:creator>
<dc:creator>Laura Rodwell</dc:creator>
<dc:creator>Niels van Royen</dc:creator>
<dc:creator>Joost P H Drenth</dc:creator>
<dc:creator>Erwin-Jan M van Geenen</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis</dc:title>
<dc:identifier>pmid:37555393</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad340</dc:identifier>
</item>
<item>
<title>SparkMaster 2: A New Software for Automatic Analysis of Calcium Spark Data</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37555352/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: SparkMaster 2 is a new, much-improved user-friendly software for accurate high-throughput analysis of line-scan Ca spark imaging data. It is free, easy to use, and provides valuable built-in features to facilitate visualization, analysis, and interpretation of Ca spark data. It should enhance the quality and throughput of Ca spark and wave analysis across cell types, particularly in the study of arrhythmogenic Ca release events in cardiomyocytes.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 9. doi: 10.1161/CIRCRESAHA.123.322847. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Calcium (Ca) sparks are elementary units of subcellular Ca release in cardiomyocytes and other cells. Accordingly, Ca spark imaging is an essential tool for understanding the physiology and pathophysiology of Ca handling and is used to identify new drugs targeting Ca-related cellular dysfunction (eg, cardiac arrhythmias). The large volumes of imaging data produced during such experiments require accurate and high-throughput analysis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We developed a new software tool SparkMaster 2 (SM2) for the analysis of Ca sparks imaged by confocal line-scan microscopy, combining high accuracy, flexibility, and user-friendliness. SM2 is distributed as a stand-alone application requiring no installation. It can be controlled using a simple-to-use graphical user interface, or using Python scripting.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: SM2 is shown to have the following strengths: (1) high accuracy at identifying Ca release events, clearly outperforming previous highly successful software SparkMaster; (2) multiple types of Ca release events can be identified using SM2: Ca sparks, waves, miniwaves, and long sparks; (3) SM2 can accurately split and analyze individual sparks within spark clusters, a capability not handled adequately by prior tools. We demonstrate the practical utility of SM2 in 2 case studies, investigating how Ca levels affect spontaneous Ca release, and how large-scale release events may promote release refractoriness. SM2 is also useful in atrial and smooth muscle myocytes, across different imaging conditions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: SparkMaster 2 is a new, much-improved user-friendly software for accurate high-throughput analysis of line-scan Ca spark imaging data. It is free, easy to use, and provides valuable built-in features to facilitate visualization, analysis, and interpretation of Ca spark data. It should enhance the quality and throughput of Ca spark and wave analysis across cell types, particularly in the study of arrhythmogenic Ca release events in cardiomyocytes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37555352/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37555352</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.322847>10.1161/CIRCRESAHA.123.322847</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37555352</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Jakub Tomek</dc:creator>
<dc:creator>Madeline Nieves-Cintron</dc:creator>
<dc:creator>Manuel F Navedo</dc:creator>
<dc:creator>Christopher Y Ko</dc:creator>
<dc:creator>Donald M Bers</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>SparkMaster 2: A New Software for Automatic Analysis of Calcium Spark Data</dc:title>
<dc:identifier>pmid:37555352</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.322847</dc:identifier>
</item>
<item>
<title>Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37555345/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: PCI was not associated with a reduction in all-cause mortality or aborted sudden death. In patients with ischemic cardiomyopathy, PCI is not beneficial solely for the purpose of reducing potentially fatal ventricular arrhythmias.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 9. doi: 10.1161/CIRCULATIONAHA.123.065300. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Ventricular arrhythmia is an important cause of mortality in patients with ischemic left ventricular dysfunction. Revascularization with coronary artery bypass graft or percutaneous coronary intervention is often recommended for these patients before implantation of a cardiac defibrillator because it is assumed that this may reduce the incidence of fatal and potentially fatal ventricular arrhythmias, although this premise has not been evaluated in a randomized trial to date.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Patients with severe left ventricular dysfunction, extensive coronary disease, and viable myocardium were randomly assigned to receive either percutaneous coronary intervention (PCI) plus optimal medical and device therapy (OMT) or OMT alone. The composite primary outcome was all-cause death or aborted sudden death (defined as an appropriate implantable cardioverter defibrillator therapy or a resuscitated cardiac arrest) at a minimum of 24 months, analyzed as time to first event on an intention-to-treat basis. Secondary outcomes included cardiovascular death or aborted sudden death, appropriate implantable cardioverter defibrillator (ICD) therapy or sustained ventricular arrhythmia, and number of appropriate ICD therapies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Between August 28, 2013, and March 19, 2020, 700 patients were enrolled across 40 centers in the United Kingdom. A total of 347 patients were assigned to the PCI+OMT group and 353 to the OMT alone group. The mean age of participants was 69 years; 88% were male; 56% had hypertension; 41% had diabetes; and 53% had a clinical history of myocardial infarction. The median left ventricular ejection fraction was 28%; 53.1% had an implantable defibrillator inserted before randomization or during follow-up. All-cause death or aborted sudden death occurred in 144 patients (41.6%) in the PCI group and 142 patients (40.2%) in the OMT group (hazard ratio, 1.03 [95% CI, 0.82-1.30]; <i>P</i>=0.80). There was no between-group difference in the occurrence of any of the secondary outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: PCI was not associated with a reduction in all-cause mortality or aborted sudden death. In patients with ischemic cardiomyopathy, PCI is not beneficial solely for the purpose of reducing potentially fatal ventricular arrhythmias.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CLINICALTRIALS: gov; Unique identifier: NCT01920048.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37555345/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37555345</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065300>10.1161/CIRCULATIONAHA.123.065300</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37555345</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Divaka Perera</dc:creator>
<dc:creator>Holly P Morgan</dc:creator>
<dc:creator>Matthew Ryan</dc:creator>
<dc:creator>Matthew Dodd</dc:creator>
<dc:creator>Tim Clayton</dc:creator>
<dc:creator>Peter D O'Kane</dc:creator>
<dc:creator>John P Greenwood</dc:creator>
<dc:creator>Simon J Walsh</dc:creator>
<dc:creator>Roshan Weerackody</dc:creator>
<dc:creator>Adam McDiarmid</dc:creator>
<dc:creator>George Amin-Youssef</dc:creator>
<dc:creator>Julian Strange</dc:creator>
<dc:creator>Bhavik Modi</dc:creator>
<dc:creator>Timothy Lockie</dc:creator>
<dc:creator>Kai Hogrefe</dc:creator>
<dc:creator>Fozia Z Ahmed</dc:creator>
<dc:creator>Miles Behan</dc:creator>
<dc:creator>Nicholas Jenkins</dc:creator>
<dc:creator>Eltigani Abdelaal</dc:creator>
<dc:creator>Michelle Anderson</dc:creator>
<dc:creator>Stuart Watkins</dc:creator>
<dc:creator>Richard Evans</dc:creator>
<dc:creator>Christopher A Rinaldi</dc:creator>
<dc:creator>Mark C Petrie</dc:creator>
<dc:creator>REVIVED-BCIS2 Investigators</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial</dc:title>
<dc:identifier>pmid:37555345</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065300</dc:identifier>
</item>
<item>
<title>PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37555328/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: PROX1 antagonizes PDGF-B signaling partially via FOXC2 to maintain the extracellular matrix composition and prevent myxomatous degeneration of cardiac valves.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 9. doi: 10.1161/CIRCRESAHA.123.323027. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Cardiac valve disease is observed in 2.5% of the general population and 10% of the elderly people. Effective pharmacological treatments are currently not available, and patients with severe cardiac valve disease require surgery. PROX1 (prospero-related homeobox transcription factor 1) and FOXC2 (Forkhead box C2 transcription factor) are transcription factors that are required for the development of lymphatic and venous valves. We found that PROX1 and FOXC2 are expressed in a subset of valvular endothelial cells (VECs) that are located on the downstream (fibrosa) side of cardiac valves. Whether PROX1 and FOXC2 regulate cardiac valve development and disease is not known.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We used histology, electron microscopy, and echocardiography to investigate the structure and functioning of heart valves from <i>Prox1</i><sup><i>ΔVEC</i></sup> mice in which <i>Prox1</i> was conditionally deleted from VECs. Isolated valve endothelial cells and valve interstitial cells were used to identify the molecular mechanisms in vitro, which were tested in vivo by RNAScope, additional mouse models, and pharmacological approaches. The significance of our findings was tested by evaluation of human samples of mitral valve prolapse and aortic valve insufficiency.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Histological analysis revealed that the aortic and mitral valves of <i>Prox1</i><sup><i>ΔVEC</i></sup> mice become progressively thick and myxomatous. Echocardiography revealed that the aortic valves of <i>Prox1</i><sup><i>ΔVEC</i></sup> mice are stenotic<i>. FOXC2</i> was downregulated and PDGF-B (platelet-derived growth factor-B) was upregulated in the VECs of <i>Prox1</i><sup><i>ΔVEC</i></sup> mice. Conditional knockdown of FOXC2 and conditional overexpression of PDGF-B in VECs recapitulated the phenotype of <i>Prox1</i><sup><i>ΔVEC</i></sup> mice. PDGF-B was also increased in mice lacking FOXC2 and in human mitral valve prolapse and insufficient aortic valve samples. Pharmacological inhibition of PDGF-B signaling with imatinib partially ameliorated the valve defects of <i>Prox1</i><sup><i>ΔVEC</i></sup> mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: PROX1 antagonizes PDGF-B signaling partially via FOXC2 to maintain the extracellular matrix composition and prevent myxomatous degeneration of cardiac valves.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37555328/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37555328</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323027>10.1161/CIRCRESAHA.123.323027</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37555328</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Yen-Chun Ho</dc:creator>
<dc:creator>Xin Geng</dc:creator>
<dc:creator>Anna O'Donnell</dc:creator>
<dc:creator>Jaime Ibarrola</dc:creator>
<dc:creator>Amaya Fernandez-Celis</dc:creator>
<dc:creator>Rohan Varshney</dc:creator>
<dc:creator>Kumar Subramani</dc:creator>
<dc:creator>Zheila J Azartash-Namin</dc:creator>
<dc:creator>Jang Kim</dc:creator>
<dc:creator>Robert Silasi</dc:creator>
<dc:creator>Jill Wylie-Sears</dc:creator>
<dc:creator>Zahra Alvandi</dc:creator>
<dc:creator>Lijuan Chen</dc:creator>
<dc:creator>Boksik Cha</dc:creator>
<dc:creator>Hong Chen</dc:creator>
<dc:creator>Lijun Xia</dc:creator>
<dc:creator>Bin Zhou</dc:creator>
<dc:creator>Florea Lupu</dc:creator>
<dc:creator>Harold M Burkhart</dc:creator>
<dc:creator>Elena Aikawa</dc:creator>
<dc:creator>Lorin E Olson</dc:creator>
<dc:creator>Jasimuddin Ahamed</dc:creator>
<dc:creator>Natalia López-Andrés</dc:creator>
<dc:creator>Joyce Bischoff</dc:creator>
<dc:creator>Katherine E Yutzey</dc:creator>
<dc:creator>R Sathish Srinivasan</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves</dc:title>
<dc:identifier>pmid:37555328</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323027</dc:identifier>
</item>
<item>
<title>Epigenetic Induction of Smooth Muscle Cell Phenotypic Alterations in Aortic Aneurysms and Dissections</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37555319/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Our study reveals the dynamic epigenetic induction of SMC phenotypic alterations in AAD. DNA damage and cytosolic leakage drive SMCs from a contractile phenotype to an inflammatory phenotype.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 9. doi: 10.1161/CIRCULATIONAHA.123.063332. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Smooth muscle cell (SMC) phenotypic switching has been increasingly detected in aortic aneurysm and dissection (AAD) tissues. However, the diverse SMC phenotypes in AAD tissues and the mechanisms driving SMC phenotypic alterations remain to be identified.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We examined the transcriptomic and epigenomic dynamics of aortic SMC phenotypic changes in mice with angiotensin II-induced AAD by using single-cell RNA sequencing and single-cell sequencing assay for transposase-accessible chromatin. SMC phenotypic alteration in aortas from patients with ascending thoracic AAD was examined by using single-cell RNA sequencing analysis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Single-cell RNA sequencing analysis revealed that aortic stress induced the transition of SMCs from a primary contractile phenotype to proliferative, extracellular matrix-producing, and inflammatory phenotypes. Lineage tracing showed the complete transformation of SMCs to fibroblasts and macrophages. Single-cell sequencing assay for transposase-accessible chromatin analysis indicated that these phenotypic alterations were controlled by chromatin remodeling marked by the reduced chromatin accessibility of contractile genes and the induced chromatin accessibility of genes involved in proliferation, extracellular matrix, and inflammation. IRF3 (interferon regulatory factor 3), a proinflammatory transcription factor activated by cytosolic DNA, was identified as a key driver of the transition of aortic SMCs from a contractile phenotype to an inflammatory phenotype. In cultured SMCs, cytosolic DNA signaled through its sensor STING-TBK1 (tank-binding kinase 1) to activate IRF3, which bound and recruited EZH2 (enhancer of zeste homolog 2) to contractile genes to induce repressive H3K27me3 modification and contractile gene suppression. In contrast, double-stranded DNA-STING-IRF3 signaling induced inflammatory gene expression in SMCs. In <i>Sting</i><sup><i>-/-</i></sup> mice, the aortic stress-induced transition of SMCs into an inflammatory phenotype was prevented, and SMC populations were preserved. Finally, profound SMC phenotypic alterations toward diverse directions were detected in human ascending thoracic AAD tissues.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our study reveals the dynamic epigenetic induction of SMC phenotypic alterations in AAD. DNA damage and cytosolic leakage drive SMCs from a contractile phenotype to an inflammatory phenotype.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37555319/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37555319</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.063332>10.1161/CIRCULATIONAHA.123.063332</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37555319</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Abhijit Chakraborty</dc:creator>
<dc:creator>Yanming Li</dc:creator>
<dc:creator>Chen Zhang</dc:creator>
<dc:creator>Yang Li</dc:creator>
<dc:creator>Kimberly R Rebello</dc:creator>
<dc:creator>Shengyu Li</dc:creator>
<dc:creator>Samantha Xu</dc:creator>
<dc:creator>Hernan G Vasquez</dc:creator>
<dc:creator>Lin Zhang</dc:creator>
<dc:creator>Wei Luo</dc:creator>
<dc:creator>Guangyu Wang</dc:creator>
<dc:creator>Kaifu Chen</dc:creator>
<dc:creator>Joseph S Coselli</dc:creator>
<dc:creator>Scott A LeMaire</dc:creator>
<dc:creator>Ying H Shen</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Epigenetic Induction of Smooth Muscle Cell Phenotypic Alterations in Aortic Aneurysms and Dissections</dc:title>
<dc:identifier>pmid:37555319</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.063332</dc:identifier>
</item>
<item>
<title>Stunning tornado: severe pulmonary hypertension due to cor triatriatum sinister</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37554080/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 9:ehad505. doi: 10.1093/eurheartj/ehad505. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37554080/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37554080</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad505>10.1093/eurheartj/ehad505</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37554080</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Xuan Zheng</dc:creator>
<dc:creator>Jinsong Cao</dc:creator>
<dc:creator>Gangcheng Zhang</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Stunning tornado: severe pulmonary hypertension due to cor triatriatum sinister</dc:title>
<dc:identifier>pmid:37554080</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad505</dc:identifier>
</item>
<item>
<title>Refractory pulmonary artery intimal sarcoma</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37554064/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 9:ehad500. doi: 10.1093/eurheartj/ehad500. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37554064/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37554064</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad500>10.1093/eurheartj/ehad500</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37554064</guid>
<pubDate>Wed, 09 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Shogo Ito</dc:creator>
<dc:creator>Nobuhiro Tahara</dc:creator>
<dc:creator>Yoshihiro Fukumoto</dc:creator>
<dc:date>2023-08-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Refractory pulmonary artery intimal sarcoma</dc:title>
<dc:identifier>pmid:37554064</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad500</dc:identifier>
</item>
<item>
<title>Cooperative assembly confers regulatory specificity and long-term genetic circuit stability</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37552983/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>A ubiquitous feature of eukaryotic transcriptional regulation is cooperative self-assembly between transcription factors (TFs) and DNA cis-regulatory motifs. It is thought that this strategy enables specific regulatory connections to be formed in gene networks between otherwise weakly interacting, low-specificity molecular components. Here, using synthetic gene circuits constructed in yeast, we find that high regulatory specificity can emerge from cooperative, multivalent interactions among...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 1:S0092-8674(23)00745-6. doi: 10.1016/j.cell.2023.07.012. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A ubiquitous feature of eukaryotic transcriptional regulation is cooperative self-assembly between transcription factors (TFs) and DNA cis-regulatory motifs. It is thought that this strategy enables specific regulatory connections to be formed in gene networks between otherwise weakly interacting, low-specificity molecular components. Here, using synthetic gene circuits constructed in yeast, we find that high regulatory specificity can emerge from cooperative, multivalent interactions among artificial zinc-finger-based TFs. We show that circuits "wired" using the strategy of cooperative TF assembly are effectively insulated from aberrant misregulation of the host cell genome. As we demonstrate in experiments and mathematical models, this mechanism is sufficient to rescue circuit-driven fitness defects, resulting in genetic and functional stability of circuits in long-term continuous culture. Our naturally inspired approach offers a simple, generalizable means for building high-fidelity, evolutionarily robust gene circuits that can be scaled to a wide range of host organisms and applications.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37552983/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37552983</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.012>10.1016/j.cell.2023.07.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37552983</guid>
<pubDate>Tue, 08 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Meghan D J Bragdon</dc:creator>
<dc:creator>Nikit Patel</dc:creator>
<dc:creator>James Chuang</dc:creator>
<dc:creator>Ethan Levien</dc:creator>
<dc:creator>Caleb J Bashor</dc:creator>
<dc:creator>Ahmad S Khalil</dc:creator>
<dc:date>2023-08-08</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Cooperative assembly confers regulatory specificity and long-term genetic circuit stability</dc:title>
<dc:identifier>pmid:37552983</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.012</dc:identifier>
</item>
<item>
<title>Constrictive calcific pericarditis leading to the compression of left ventricular myocardium indicated by cardiac dual-energy computed tomography angiography</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37552645/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 8:ehad466. doi: 10.1093/eurheartj/ehad466. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37552645/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37552645</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad466>10.1093/eurheartj/ehad466</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37552645</guid>
<pubDate>Tue, 08 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Kailu Zhang</dc:creator>
<dc:creator>Yukun Cao</dc:creator>
<dc:creator>Heshui Shi</dc:creator>
<dc:date>2023-08-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Constrictive calcific pericarditis leading to the compression of left ventricular myocardium indicated by cardiac dual-energy computed tomography angiography</dc:title>
<dc:identifier>pmid:37552645</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad466</dc:identifier>
</item>
<item>
<title>An unexpected fall from GRACE</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37552635/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 8:ehad468. doi: 10.1093/eurheartj/ehad468. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37552635/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37552635</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad468>10.1093/eurheartj/ehad468</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37552635</guid>
<pubDate>Tue, 08 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:date>2023-08-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>An unexpected fall from GRACE</dc:title>
<dc:identifier>pmid:37552635</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad468</dc:identifier>
</item>
<item>
<title>Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37551634/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 8:ehad483. doi: 10.1093/eurheartj/ehad483. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37551634/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37551634</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad483>10.1093/eurheartj/ehad483</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37551634</guid>
<pubDate>Tue, 08 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Jeremy P Moore</dc:creator>
<dc:creator>Jamil A Aboulhosn</dc:creator>
<dc:creator>Paul Khairy</dc:creator>
<dc:date>2023-08-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot</dc:title>
<dc:identifier>pmid:37551634</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad483</dc:identifier>
</item>
<item>
<title>Organ Donation After Out-of-Hospital Cardiac Arrest: A Scientific Statement From the International Liaison Committee on Resuscitation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37551611/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: All health systems should develop, implement, and evaluate protocols designed to optimize organ donation opportunities for patients who have an out-of-hospital cardiac arrest and failed attempts at resuscitation.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 8. doi: 10.1161/CIR.0000000000001125. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM OF THE REVIEW: Improving rates of organ donation among patients with out-of-hospital cardiac arrest who do not survive is an opportunity to save countless lives. The objectives of this scientific statement were to do the following: define the opportunity for organ donation among patients with out-of-hospital cardiac arrest; identify challenges and opportunities associated with organ donation by patients with cardiac arrest; identify strategies, including a generic protocol for organ donation after cardiac arrest, to increase the rate and consistency of organ donation from this population; and provide rationale for including organ donation as a key clinical outcome for all future cardiac arrest clinical trials and registries.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The scope of this International Liaison Committee on Resuscitation scientific statement was approved by the International Liaison Committee on Resuscitation board and the American Heart Association, posted on ILCOR.org for public comment, and then assigned by section to primary and secondary authors. A unique literature search was completed and updated for each section.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: There are a number of defining pathways for patients with out-of-hospital cardiac arrest to become organ donors; however, modifications in the Maastricht classification system need to be made to correctly identify these donors and to report outcomes with consistency. Suggested modifications to the minimum data set for reporting cardiac arrests will increase reporting of organ donation as an important resuscitation outcome. There are a number of challenges with implementing uncontrolled donation after cardiac death protocols, and the greatest impediment is the lack of legislation in most countries to mandate organ donation as the default option. Extracorporeal cardiopulmonary resuscitation has the potential to increase organ donation rates, but more research is needed to derive neuroprognostication rules to guide clinical decision-making about when to stop extracorporeal cardiopulmonary resuscitation and to evaluate cost-effectiveness.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: All health systems should develop, implement, and evaluate protocols designed to optimize organ donation opportunities for patients who have an out-of-hospital cardiac arrest and failed attempts at resuscitation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37551611/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37551611</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001125>10.1161/CIR.0000000000001125</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37551611</guid>
<pubDate>Tue, 08 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Laurie J Morrison</dc:creator>
<dc:creator>Claudio Sandroni</dc:creator>
<dc:creator>Brian Grunau</dc:creator>
<dc:creator>Michael Parr</dc:creator>
<dc:creator>Finlay Macneil</dc:creator>
<dc:creator>Gavin D Perkins</dc:creator>
<dc:creator>Mayuki Aibiki</dc:creator>
<dc:creator>Eileen Censullo</dc:creator>
<dc:creator>Steve Lin</dc:creator>
<dc:creator>Robert W Neumar</dc:creator>
<dc:creator>Steven C Brooks</dc:creator>
<dc:creator>International Liaison Committee on Resuscitation</dc:creator>
<dc:date>2023-08-08</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Organ Donation After Out-of-Hospital Cardiac Arrest: A Scientific Statement From the International Liaison Committee on Resuscitation</dc:title>
<dc:identifier>pmid:37551611</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001125</dc:identifier>
</item>
<item>
<title>Coronary microvascular dysfunction: from Cinderella to Princess</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37549234/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230810000958&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 7;44(30):2791-2794. doi: 10.1093/eurheartj/ehad498.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37549234/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230810000958&v=2.17.9.post6+86293ac">37549234</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad498>10.1093/eurheartj/ehad498</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37549234</guid>
<pubDate>Mon, 07 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2023-08-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Coronary microvascular dysfunction: from Cinderella to Princess</dc:title>
<dc:identifier>pmid:37549234</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad498</dc:identifier>
</item>





























</channel>
</rss>